ARCHIVES

FDA Says ImClone Data Insufficient To Evaluate Colorectal Cancer Drug C225.

This article is from The Cancer Letter archive.

Vol. 28 No. | March 8, 2002

Download PDF Visit The Full Archive

Related Articles

Experts Call For Large International Study Of Mammography Screening In Ages 40-42

October 15, 1993

Retrovirus Vaccination Is Feasible, Workshop Participants Conclude

May 3, 1985

Rall Supports Animal Tests; Carcinogenesis Reports Summarized

May 13, 1977

Austria Has highest Cancer Rate, Little NCI Support

June 17, 1977

Study Finds No Link Between Pill And Breast Cancer Risk

July 26, 2002

New Ethics Rules Stir Anger, Disaffection at NIH, Scientists to Prepare a Legal Challenge.

February 11, 2005